PubHawk
April 2024 PMID 38808490

Shuo Wang, Chun-Mei Deng, Yuan Zeng, Xin-Zhong Chen, Ai-Yuan Li, Shan-Wu Feng, Li-Li Xu, Liang Chen, Hong-Mei Yuan, Han Hu, Tian Yang, Tao Han, Hui-Ying Zhang, Ming Jiang, Xin-Yu Sun

Full text PDF Download social card

Mentions

81
Peak: 18 in Apr 2024
across 5 sources since Apr 2024

Extended reach

31,032
potential audience

Total likes

69

Video views

459

Mentions per month

Apr 2024 – Jun 2024

Where it's discussed

  • News52 articles
  • X / Twitter18 posts
  • Blogs5 articles
  • Facebook4 posts
  • YouTube2 videos

AI synopsis

What people are saying

Discussions reference the study's positive outcomes, with phrases like 'lower risk of postpartum depression' and 'effective treatment' demonstrating recognition of its importance, while tone remains generally supportive and straightforward, emphasizing the potential benefits of low-dose esketamine.

AgreementModerate agreement

Most discussions acknowledge the positive findings about esketamine's effectiveness in reducing postpartum depression, indicating general agreement with the study's conclusions.

InterestModerate interest

The posts show moderate interest, focusing on key results like the lower depression rates, but lack deep exploration of the methodology or broader implications.

EngagementModerate engagement

Posts briefly mention the trial and results, reflecting some engagement but not detailed analysis or extensive discussion.

ImpactModerate impact

Comments suggest that the findings could influence postpartum care practices, highlighting potential clinical significance.

Abstract in brief

  • The study aimed to assess if a single low dose of esketamine given after childbirth can help reduce postpartum depression in mothers with prenatal depression.
  • A total of 364 mothers were randomly assigned to receive either esketamine or a placebo after delivery, with the primary measure being the incidence of major depressive episodes 42 days later.
  • The results showed significantly lower rates of depression in the esketamine group compared to the placebo, with notable improvements in depression scores at both seven and 42 days after childbirth.
Read the full abstract

Top posts

Most liked on X and Bluesky
Alexis R. | METODOLOGICA_CL
@metodologica_cl · X

Apr 11, 2024 · 52 likes · 18 shares · 3,807 followers View post →
Vera Wilde
@vk_wilde · X

"Efficacy of a single low dose of esketamine after childbirth for mothers with symptoms of prenatal depression: randomised clinical trial," Wang et al, BMJ, 2024 Apr 10:385:e078218 https://t.co/m6iri0LI8P IV esketamine lowered risk of postpartum depression...

Jun 2, 2024 · 1 like · 1 share · 890 followers View post →
Chini
@_hipotenusa1 · X

RT @metodologica_cl:

Apr 11, 2024 · 18 shares · 8,607 followers View post →
Isabel
@otonista · X

RT @metodologica_cl:

Apr 11, 2024 · 18 shares · 5,132 followers View post →
Francisco Figueroa
@PanchoFigueroas · X

RT @metodologica_cl:

Apr 11, 2024 · 18 shares · 2,618 followers View post →
Rodrigo Arroyo
@arroyorodrigo · X

RT @metodologica_cl:

Apr 11, 2024 · 18 shares · 2,119 followers View post →

All mentions

WaNe
@WaNeInTime · X

RT @vk_wilde: "Efficacy of a single low dose of esketamine after childbirth for mothers with symptoms of prenatal depression: randomised cl…

Jun 2, 2024 · 1 share · 547 followers View post →
Vera Wilde
@vk_wilde · X

"Efficacy of a single low dose of esketamine after childbirth for mothers with symptoms of prenatal depression: randomised clinical trial," Wang et al, BMJ, 2024 Apr 10:385:e078218 https://t.co/m6iri0LI8P IV esketamine lowered risk of postpartum depression...

Jun 2, 2024 · 1 like · 1 share · 890 followers View post →
Arturo Trostel
@XxTurok · X

RT @metodologica_cl:

Apr 11, 2024 · 18 shares · 200 followers View post →
nabiki_aprueba
@nabiki_aprueba · X

RT @metodologica_cl:

Apr 11, 2024 · 18 shares · 538 followers View post →
Loper fecto
@Raulloper2002 · X

RT @metodologica_cl:

Apr 11, 2024 · 18 shares · 429 followers View post →
FREE_PALESTINE
@foraneostereo · X

RT @metodologica_cl:

Apr 11, 2024 · 18 shares · 1,858 followers View post →
Chini
@_hipotenusa1 · X

RT @metodologica_cl:

Apr 11, 2024 · 18 shares · 8,607 followers View post →
jczeta31
@jczeta31 · X

RT @metodologica_cl:

Apr 11, 2024 · 18 shares · 484 followers View post →
aleja
@larva5612 · X

RT @metodologica_cl:

Apr 11, 2024 · 18 shares · 17 followers View post →
Francisco Figueroa
@PanchoFigueroas · X

RT @metodologica_cl:

Apr 11, 2024 · 18 shares · 2,618 followers View post →
Ignacio Yaeger
@nachosdinos · X

RT @metodologica_cl:

Apr 11, 2024 · 18 shares · 394 followers View post →
alfonso hernández
@alfonsoher_mol · X

RT @metodologica_cl:

Apr 11, 2024 · 18 shares · 438 followers View post →
Dominick D'cocco
@Cristianofxx · X

RT @metodologica_cl:

Apr 11, 2024 · 18 shares · 1,299 followers View post →
Isabel
@otonista · X

RT @metodologica_cl:

Apr 11, 2024 · 18 shares · 5,132 followers View post →
Ricardo Pino
@Ricardo_Pino1 · X

RT @metodologica_cl:

Apr 11, 2024 · 18 shares · 167 followers View post →
Rafael A García Araya
@ragarciaaraya · X

RT @metodologica_cl:

Apr 11, 2024 · 18 shares · 449 followers View post →
Rodrigo Arroyo
@arroyorodrigo · X

RT @metodologica_cl:

Apr 11, 2024 · 18 shares · 2,119 followers View post →
Alexis R. | METODOLOGICA_CL
@metodologica_cl · X

Apr 11, 2024 · 52 likes · 18 shares · 3,807 followers View post →